GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Citius Pharmaceuticals CTXR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.53

-3.45%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Citius Pharmaceuticals

Our reporting

We have not reported on Citius Pharmaceuticals yet.

Next results

22 Dec 2026

Due on 22 Dec 2026. Analysts expect earnings of -0.41 a share on revenue of $2.9m.

Past results

Reported against what analysts expected

14 Aug 202615 May 202613 Feb 202626 Dec 202512 Aug 202514 Feb 2025
Earnings per share-0.34-0.95-0.38-0.01-0.80-1.30
Forecast-0.36-0.280.43-0.43-0.24-1.25
Revenue$1.5m$1.7m$3.9m$3.9m——
Forecast$5.5m$10.2m$18.0m$5.8m$1.9m$2.7m

Key events

  1. 26 Nov 202425-to-1 reverse split
  2. 3 Aug 2017Listed
  3. 9 Jun 201715-to-1 reverse split
  4. 12 Sept 20141.6-to-1 reverse split

Citius Pharmaceuticals in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.